Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications

Free
Message: Denselight and blood glucose

Like Biopharma:

3 phases! After Phase 3 you receive the FDA approval.

GLTA

Share
New Message
Please login to post a reply